Transfusion and Apheresis Science
Volume 37, Issue 1 , Pages 37-41, August 2007

Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?

  • Volker Diehl

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +49 221 478 86653; fax: +49 221 478 86654.
    • ,
  • Michael Fuchs
    • ,
  • On behalf of the German Hodgkin Lymphoma Study Group (GHSG)

University of Cologne, Joseph-Stelzmann Strasse 9, 50924 Koln, Germany

Received 11 April 2007; accepted 24 April 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1473-0502(07)00093-6

doi:10.1016/j.transci.2007.04.004

Transfusion and Apheresis Science
Volume 37, Issue 1 , Pages 37-41, August 2007

Article Tools